Back to Search
HARRISON FARBER, M.D.
M.D.
Pulmonary Disease Physician
NPI: 1396721841IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
47862(MA)
Pulmonary Disease PhysicianPrimary
Internal Medicine — Pulmonary Disease
Code: 207RP1001X
47862(MA)
Education
GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
Class of 1977
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
Pulmonary hemodynamic responses to brain natriuretic peptide and sildenafil in patients with pulmonary arterial hypertension.
PMID 16478861·Chest·2006
8-other
Use of asthma medication dispensing patterns to predict risk of adverse health outcomes: a study of Medicaid-insured children in managed care programs.
PMID 15049395·Ann Allergy Asthma Immunol·2004
8-other
Misunderstanding of asthma controller medications: association with nonadherence.
PMID 12699208·J Asthma·2003
8-other
ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association.
PMID 19389575·J Am Coll Cardiol·2009
6-review
Adiponectin deficiency: a model of pulmonary hypertension associated with pulmonary vascular disease.
PMID 19561137·Am J Physiol Lung Cell Mol Physiol·2009
7-preclinical
Dosing considerations in the use of intravenous prostanoids in pulmonary arterial hypertension: an experience-based review.
PMID 19332188·Am Heart J·2009
6-review
Effect of sodium butyrate on lung vascular TNFSF15 (TL1A) expression: differential expression patterns in pulmonary artery and microvascular endothelial cells.
PMID 19251437·Cytokine·2009
8-other
Secondhand tobacco smoke in children with asthma: sources of and parental perceptions about exposure in children and parental readiness to change.
PMID 18339788·Chest·2008
4-observational
Pulmonary arterial hypertension and left-sided heart disease in sickle cell disease: clinical characteristics and association with soluble adhesion molecule expression.
PMID 18383329·Am J Hematol·2008
8-other
On the importance of plasmalogen status in stimulated arachidonic acid release in the macrophage cell line RAW 264.7.
PMID 18328831·Biochim Biophys Acta·2008
7-preclinical
Design of the REVEAL registry for US patients with pulmonary arterial hypertension.
PMID 18674477·Mayo Clin Proc·2008
4-observational
Identification of oxidative post-translational modification of serum albumin in patients with idiopathic pulmonary arterial hypertension and pulmonary hypertension of sickle cell anemia.
PMID 17569101·Rapid Commun Mass Spectrom·2007
8-other
Imatinib mesylate in the treatment of refractory idiopathic pulmonary arterial hypertension.
PMID 16847299·Ann Intern Med·2006
5-case
Conversion to bosentan from prostacyclin infusion therapy in pulmonary arterial hypertension: a pilot study.
PMID 17099026·Chest·2006
3-trial
Sarcoidosis-associated pulmonary hypertension: outcome with long-term epoprostenol treatment.
PMID 17099027·Chest·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 725 ALBANY ST, SHAPIRO 9, SUITE B
BOSTON, MA 02118 - Phone
- (617) 638-7480
Quick Facts
- NPI
- 1396721841
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 49
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile